Neko Health raises $700M Series C at ~$7bn valuation
What's the deal? Neko Health, the Swedish preventative-health startup, has raised a $700M Series C at a valuation just shy of $7bn (July 2026). The round was led by Lightspeed Venture Partners (Bejul Somaia) and co-led by O.G. Venture PartnersDealroom has a profile for this one. Try Dealroom →.
Who's behind it? Neko was founded by Spotify's Daniel EkDealroom has a profile for this one. Try Dealroom → and Hjalmar NilsonneDealroom has a profile for this one. Try Dealroom →. At the heart of its offering is the Neko Health Scan — a 60-minute, non-invasive, radiation-free health assessment capturing millions of data points.
Why it matters. The company became a unicorn on the back of its $260M Series B in early 2025, and more than 100,000 people have now had a scan. The new capital funds a large US expansion programme.
Read more: Seb Johnson (LinkedIn)
